Related Experiment Video
Updated: Aug 8, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation
T Frappier1, N S Liang, K Brown
1Department of Pathology and Taub Center for Alzheimer's Disease Research, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Abstract:
Mutations in the gene for the microtubule associated protein, tau have been identified for fronto-temporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17). In vitro data have shown that FTDP-17 mutant tau proteins have a reduced ability to bind microtubules and to promote microtubule assembly. Using the baculovirus system we have examined the effect of the V337M mutation on the organization of the microtubules at the ultrastructural level. Our results show that the organization of the microtubules is disrupted in the presence of V337M tau with greater distances between the microtubules and fewer microtubules per process.
Insights
Mutant tau protein (V337M) disrupts microtubule organization, impacting cellular structure. This finding offers insights into frontotemporal dementia with Parkinsonism (FTDP-17) pathogenesis.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Mutations in tau protein are linked to frontotemporal dementia with Parkinsonism (FTDP-17).
- FTDP-17 mutant tau proteins exhibit reduced microtubule binding and assembly promotion.
- Understanding tau's role in microtubule organization is crucial for neurodegenerative disease research.
Purpose of the Study:
- To investigate the ultrastructural effects of the V337M tau mutation on microtubule organization.
- To elucidate the impact of specific tau mutations on cellular microtubule dynamics.
Main Methods:
- Utilized the baculovirus expression system to study the V337M tau mutation.
- Examined microtubule organization at the ultrastructural level.
Main Results:
- The V337M tau mutation disrupts microtubule organization.
- Presence of V337M tau leads to increased spacing between microtubules.
- Fewer microtubules were observed per cellular process in the presence of V337M tau.
Conclusions:
- The V337M mutation in tau protein alters microtubule organization.
- Disrupted microtubule organization may contribute to the pathogenesis of FTDP-17.
- Further research into tau-microtubule interactions is warranted for understanding neurodegenerative mechanisms.
More Related Videos
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Destabilization of Microtubules
Assembly of Complex Microtubule Structures
Microtubules in Cell Motility
Drugs that Stabilize Microtubules
Microtubule Instability

